| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | +77.0% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $4.4M | +23.5% |
| SG&A Expense | $45.2M | +14.3% |
| Operating Income | -$16.5M | +55.3% |
| Pre-tax Income | -$15.1M | +58.8% |
| Income Tax | $1.3M | +28.4% |
| Net Income | -$16.3M | +56.5% |
| EPS (Basic) | -$0.87 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.2M | -59.1% |
| Current Assets | $59.5M | -48.6% |
| Total Assets | $278.6M | +0.2% |
| Current Liabilities | $31.9M | +231.1% |
| Total Liabilities | $98.8M | +7.7% |
| Stockholders' Equity | $179.8M | -3.5% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.3M | -252.1% |
| Capital Expenditures | $2.1M | +101.9% |
| Investing Cash Flow | -$27.1M | +1.0% |
| Financing Cash Flow | -$8.1M | -233.7% |
| Free Cash Flow | -$29.4M | -274.2% |
| +58.0% |
| EPS (Diluted) | -$0.87 | +58.0% |